Blumer D. Epilepsy and suicide: a neuropsychiatric analysis. The neuropsychiatry of epilepsy, 2002: 107-116.

Kanner AM. Do epilepsy and psychiatric disorders share common pathogenic mechanisms? A look at depression and epilepsy. Clinical Neuroscience Research, 2004, 4: 31–37.

Kanner AM. Corrigendum to Depression and epilepsy: Epidemiologic and neurobiologic perspectives that may explain their high comorbid occurrence. Epilepsy & Behavior, 2014, 32: 170.

Mula M. The interictal dysphoric disorder of epilepsy: a still open debate. Curr Neurol Neurosci Rep., 2013, 13(6): 355.

Phabphal K, Sattawatcharawanich S, Sathirapunya P, Limapichart K. Anxiety and depression in Thai epileptic patients. J. Med. Assoc. Thai., 2007, 90(10): 2010–5.

Mazarati A, Siddarth P, Baldwin RA, Shin D, Caplan R, Sankar R. Depression after status epilepticus: behavioural and biochemical deficits and effects of fluoxetine. Brain, 2008, 131(8): 2071–83.

Thapar A, Kerr M, Harold G. Stress, anxiety, depression, and epilepsy: investigating the relationship between psychological factors and seizures. Epilepsy Behav, 2009, 14(1): 134–40.

Mehndiratta P, Sajatovic M. Treatments for patients with comorbid epilepsy and depression: a systematic literature review. Epilepsy Behav, 2013, 28(1): 36–40.

Mula M. Treatment of anxiety disorders in epilepsy: an evidence-based approach. Epilepsia. 2013, 54.

Elger CE, Schmidt D. Modern management of epilepsy: a practical approach. Epilepsy Behav, 2008, 12(4): 501–39.

Kanner AM. Depression and epilepsy: a new perspective on two closely related disorders. Epilepsy Curr, 2006, 6(5): 141–6.

Fisher PL, Noble AJ. Anxiety and depression in people with epilepsy. The contribution of meta-cognitive beliefs, 2017, 50: 153-159.

Kanner AM. Psychiatric comorbidities in new onset epilepsy: Should they be always investigated? Seizure, 2017, 49: 79-82.

Fisher PL, Noble AJ. Anxiety and depression in people with epilepsy. The contribution of meta-cognitive beliefs, 2017 Aug, 50: 153-159.

Kanner AM. The treatment of depressive disorders in epilepsy: what all neurologists should know. Epilepsia, 2013, 54: 3–12.

Johannessen SI, Ben-Menachem E. Management of focal-onset seizures: an update on drug treatment. Drugs, 2006, 66(13): 1701–25.

Wiglusz MS, Cubała WJ, Gałuszko-Węgielnik M, Jakus z kowiak-Wojten K, Landowski J. Mood disorders in epilepsy - diagnostic and methodological considerations. Psychiatr Danub, 2012 Sep, 24: 44-50.

Andrade-Machado R, Ochoa-Urrea M, Garcia-Espinosa A. Suicidal risk, affective dysphoric disorders, and quality-of-life perception in patients with focal refractoryepilepsy. Epilepsy and Bihavior, 2015, 45: 254-260.

Mula M, Jauch R, Cavanna A, Gaus V, Kretz R, Collimedaglia L, Barbagli D, Cantello R, Monaco F, Schmitz B. Interictal dysphoric disorder and periictal dysphoric symptoms in patients with epilepsy. Epilepsia, 2010, 51(7): 1139–1145.

Beletsky V, Mirsattari SM. Epilepsy, Mental Health Disorder, or Both? Epilepsy Res Treat, 2012, 2012: 163731.

Andrade-Machado R, Ochoa-Urrea M, Garcia-Espi nosa A, Benjumea-Cuartas V, Santos-Santos A. Sui cidal risk, affective dysphoric disorders, and quality-of-life perception in patients with focal refractoryepilepsy. Epilepsy Behav, 2015, 45: 254-260.

De Lima C, de Lira CA, Arida RM, Andersen ML, Matos G, de Figueiredo Ferreira Guilhoto LM et al. Association between leisure time, physical activity, and mood disorder levels in individuals with epilepsy. Epilepsy Behav, 2013, 28(1): 47–51.

Kimiskidis VK, Triantafyllou NI, Kararizou E, Gatzonis SS, Fountoulakis KN, Siatouni A et al. Depression and anxiety in epilepsy: the association with demographic and seizure-related variables. Ann. Gen. Psychiatry., 2007, 6: 28.

Ribot R, Ouyang B, Kanner AM. The impact of antidepressants on seizure frequency and depressive and anxietydisorders of patients with epilepsy: Is it worth investigating? Epilepsy Behav, 2017 May, 70.

Mazarati A et al. Depression after status epilepticus: behavioural and biochemical deficits and effects of fluoxetine. Bain, 2008, 131: 2071-2083.

Kanner AM. Mood disorder and epilepsy and epilepsy: a neurobiologic perspective of their relationship. Dialogues Clin. Neurosci., 2008, 10: 39-45.

Koh S, Magid R, Chung H, Stine CD, Wilson DN. Depressive behavior and selective down-regulation of serotonin receptor expression after early-life seizures: reversal by environmental enrichment. Epilepsy Behav, 2007, 10(1): 26–31.

Woif P. Praxisbuch Epilepsien. Diagnostik, Behandlung, Rehabilitation. Kohlhammer, Stuttgart, 2003. 394 p.

Devinsky O. Is Behavior in Temporal Lobe Epilepsy Different than in Other Epilepsies? The Jury Is Out. Epilepsy Curr, 2007, 7(4): 95–96.

Dudra-Jastrzebska M et al. Mood disorders in patients with epilepsy. Pharmacological reports, 2007, 59: 369–378.

Зенков Л.Р. Фармакологическое лечение эпилепсии. РМЖ, 2000, 10: 411-7.

Loring DW, Meador KJ. Cognitive and Behavi oral

Ef fects of Epilepsy Treatment. Epilepsia, 2001, 42: 24–32.

Kanner AM. The treatment of depressive disorders in epilepsy: What all neurologists should know. Epilepsia, 2013, 54: 3–12.

Mula M, Trimble MR. Pharmacokinetic interactions between antiepileptic and antideprecant drugs. World J. Biological Psychiftry, 2003, 4: 21-24.

Kanner AM, Ribot R. Depression. In Neuro psychiatric symptoms of Epilepsy Mula M. Editor. Springer International Publishing Switzerland. 2016: 25-41

Yilmaz Z, Ceschi A, Rauber-Luthy C et al. Escitalopram causes fewer seizures in human overdose that citalopram. Clin. Toxicol. (Plila), 2010, l48: 207-212.

Specchio LM, Ludice A, Specchio N. Citalopram as treatment of depression in patients with epilepsy. Clin. Neuropharmacol., 2004, 27: 133-136.